The Telangana government is working on initiatives such as Digital Medicine Hub, Institute for Cell and Gene Therapy, Flow Chemistry Hub, a world-class life sciences university, and many more to build strong foundations for the next generation opportunities said the Minister for IT and Industries KT Rama Rao.
Genome Valley also witnessed large pharmaceutical companies announcing expansion plans. Sai Life Sciences, a contract research organisation, inaugurated its new Research & Development centre at Genome Valley with an investment of about Rs 400 crores he stated. He was speaking at the Bio-Asia meet here in Hyderabad.
GVK Bio, another Hyderabad-based company focused on supporting global innovators, is also expanding rapidly and will be adding 600 new jobs this year in Hyderabad, which highlights Hyderabad’s unmatched scientific prowess.
Another company Granules India will invest about Rs 400 crores to set up a facility with capacity to manufacture 10 billion units of finished dosages that will generate employment for about 1,600 persons. And Laurus Labs is investing Rs 300 crores to set up a formulation facility in Genome Valley with a capacity of five billion units.
The Government of Telangana is partnering with Cytiva to set up a biopharma scale up facility- B-Hub in Genome valley. “As you know, eight out of 10 top selling drugs globally today are biopharmaceuticals. I am confident that Telangana will emerge the biopharmaceutical capital of India,” said the minister.
The Medical Devices Park continues to be the destination-of-choice and around 40 companies are establishing their manufacturing and R&D facilities.
